scholarly article | Q13442814 |
P50 | author | Krzysztof Warzocha | Q11749787 |
Ewa Lech-Marańda | Q88435517 | ||
Michał Gałęzowski | Q114330797 | ||
Tomasz Sewastianik | Q114419563 | ||
Wojciech Czardybon | Q114419564 | ||
Hanna Makuch-Łasica | Q125311120 | ||
Patryk Górniak | Q59566760 | ||
Emilia Białopiotrowicz | Q59691213 | ||
Anna Polak | Q59705325 | ||
Ewa Jabłońska | Q59705333 | ||
Przemysław Juszczyński | Q59705355 | ||
Katarzyna Borg | Q59707377 | ||
Bozena Katarzyna Budziszewska | Q85253808 | ||
Maciej Szydlowski | Q86744691 | ||
Bartosz Pula | Q57028177 | ||
P2093 | author name string | Krzysztof Brzózka | |
Renata Windak | |||
Aleksandra Bluszcz | |||
Monika Noyszewska-Kania | |||
Grażyna Nowak | |||
Karolina Piechna | |||
Maja Wasylecka-Juszczyńska | |||
P2860 | cites work | Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels | Q24309167 |
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism | Q24603034 | ||
The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death | Q28204906 | ||
PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells | Q28237807 | ||
Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma | Q28275416 | ||
Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration | Q33494281 | ||
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells | Q33749658 | ||
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells | Q33830733 | ||
Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells | Q73407146 | ||
Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement | Q73900277 | ||
Expression of human pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation | Q81082199 | ||
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia | Q34542102 | ||
Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia | Q35022490 | ||
Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo | Q35781372 | ||
Activation of Pim Kinases Is Sufficient to Promote Resistance to MET Small-Molecule Inhibitors | Q36383040 | ||
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival | Q36384731 | ||
JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia | Q36544062 | ||
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival | Q36561705 | ||
BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia | Q36799197 | ||
4E-BP1, a multifactor regulated multifunctional protein | Q36838384 | ||
The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism. | Q37035832 | ||
STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia. | Q37362593 | ||
Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells | Q37414714 | ||
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia | Q37564783 | ||
From pathogenesis to treatment of chronic lymphocytic leukaemia | Q37643423 | ||
The Pim kinases: new targets for drug development | Q37903357 | ||
Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy | Q38101683 | ||
"Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia''. | Q38140625 | ||
Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation | Q38266874 | ||
PIM kinase (and Akt) biology and signaling in tumors. | Q38370023 | ||
Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment | Q38550810 | ||
Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma. | Q38683489 | ||
Prognostic Factors for Chronic Lymphocytic Leukemia | Q38691341 | ||
Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. | Q38813901 | ||
Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks. | Q38960311 | ||
PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1). | Q39012615 | ||
Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma | Q39283981 | ||
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells | Q39562043 | ||
Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. | Q39844632 | ||
FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas. | Q41111760 | ||
Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib | Q41763842 | ||
Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447. | Q42319925 | ||
Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene | Q46879250 | ||
Increased expression of E3 ubiquitin ligases targeting p53 in CLL patients with wild-type TP53 exhibits associations with clinical features of the disease. | Q53329470 | ||
P433 | issue | 7 | |
P921 | main subject | lymphocyte | Q715347 |
leukemia | Q29496 | ||
chronic lymphocytic leukemia | Q1088156 | ||
P304 | page(s) | 3548-3559 | |
P577 | publication date | 2018-04-17 | |
P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
P1476 | title | Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration | |
P478 | volume | 22 |
Q58738700 | CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase |
Q91684508 | Characteristics of live parameters of the HS-5 human bone marrow stromal cell line cocultured with the leukemia cells in hypoxia, for the studies of leukemia-stroma cross-talk |
Q61798674 | Molecular Players in Hematologic Tumor Cell Trafficking |
Q90705620 | Platelet-derived growth factor-BB promotes proliferation and migration of retinal microvascular pericytes by up-regulating the expression of C-X-C chemokine receptor types 4 |
Search more.